ZA200000370B - Novel antigenic class of avian reoviruses. - Google Patents

Novel antigenic class of avian reoviruses.

Info

Publication number
ZA200000370B
ZA200000370B ZA200000370A ZA200000370A ZA200000370B ZA 200000370 B ZA200000370 B ZA 200000370B ZA 200000370 A ZA200000370 A ZA 200000370A ZA 200000370 A ZA200000370 A ZA 200000370A ZA 200000370 B ZA200000370 B ZA 200000370B
Authority
ZA
South Africa
Prior art keywords
avian reoviruses
novel antigenic
antigenic class
class
reoviruses
Prior art date
Application number
ZA200000370A
Other languages
English (en)
Inventor
Adriaan Anthonius Wilhelm Loon
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA200000370B publication Critical patent/ZA200000370B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA200000370A 1999-01-29 2000-01-27 Novel antigenic class of avian reoviruses. ZA200000370B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200259 1999-01-29

Publications (1)

Publication Number Publication Date
ZA200000370B true ZA200000370B (en) 2000-08-07

Family

ID=8239847

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200000370A ZA200000370B (en) 1999-01-29 2000-01-27 Novel antigenic class of avian reoviruses.

Country Status (16)

Country Link
US (1) US6951650B1 (xx)
EP (1) EP1024189B1 (xx)
JP (2) JP4659942B2 (xx)
KR (1) KR100583259B1 (xx)
AT (1) ATE292674T1 (xx)
AU (1) AU759179B2 (xx)
BR (1) BR0000190A (xx)
CA (1) CA2297345C (xx)
DE (1) DE60019178T2 (xx)
ES (1) ES2240005T3 (xx)
HU (1) HU225434B1 (xx)
MX (1) MXPA00001001A (xx)
PL (1) PL192277B1 (xx)
PT (1) PT1024189E (xx)
RU (1) RU2265659C2 (xx)
ZA (1) ZA200000370B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1700929A (zh) * 2002-09-16 2005-11-23 惠氏公司 含有禽吸收障碍综合征相关病毒的疫苗及其给药方法
AU2003296912A1 (en) * 2002-10-09 2004-05-04 Akzo Nobel N.V. Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
WO2008076518A2 (en) * 2006-10-25 2008-06-26 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
EP2304024A2 (en) 2008-06-26 2011-04-06 Biomune Company Avian reoviridae
WO2010059899A2 (en) * 2008-11-20 2010-05-27 University Of Georgia Research Foundation, Inc. Vaccine for runting-stunting syndrome
CA2725435C (en) * 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
KR101600959B1 (ko) 2013-06-18 2016-03-08 단국대학교 산학협력단 가금 레오바이러스 시그마 c 단백질의 항원 결정기를 포함하는 재조합 단백질 및 이에 대한 항체
JP6682441B2 (ja) * 2014-01-29 2020-04-15 ユニバーシティ オブ ジョージア リサーチ ファンデーション，インコーポレーテッド トリレオウイルスワクチン
EP3200820B1 (en) 2014-10-03 2023-07-05 Intervet International B.V. Broad-spectrum vaccine against avian reovirus
CN104711240B (zh) * 2015-03-18 2017-10-10 广西壮族自治区兽医研究所 禽呼肠孤病毒σA蛋白及其相关生物材料的应用
US11541111B2 (en) 2016-01-07 2023-01-03 Gavish-Galilee Bio Applications, Ltd. Optimized polypeptide for a subunit vaccine against avian reovirus
CN108794627A (zh) * 2018-07-03 2018-11-13 重庆永健生物技术有限责任公司 一种鸭呼肠孤病毒精制卵黄抗体的制备方法
CN111000992A (zh) * 2019-12-19 2020-04-14 广州渔跃生物技术有限公司 一种鸭呼肠孤病毒、鸭坦布苏病毒和鸭腺病毒三联灭活疫苗及其制备方法
CN116478937B (zh) * 2023-06-12 2023-08-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 基因iii型禽呼肠孤病毒变异株及其在制备疫苗中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559229A (en) * 1982-07-20 1985-12-17 Research Foundation Avian proventriculitis vaccine
US5525342A (en) * 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same

Also Published As

Publication number Publication date
ATE292674T1 (de) 2005-04-15
HUP0000362A3 (en) 2005-04-28
DE60019178T2 (de) 2005-09-08
RU2265659C2 (ru) 2005-12-10
PL338118A1 (en) 2000-07-31
KR20010069166A (ko) 2001-07-23
JP2000295986A (ja) 2000-10-24
EP1024189B1 (en) 2005-04-06
AU1362900A (en) 2000-08-03
CA2297345A1 (en) 2000-07-29
CA2297345C (en) 2010-07-13
DE60019178D1 (de) 2005-05-12
PL192277B1 (pl) 2006-09-29
BR0000190A (pt) 2001-08-21
US6951650B1 (en) 2005-10-04
HU225434B1 (en) 2006-11-28
EP1024189A1 (en) 2000-08-02
PT1024189E (pt) 2005-08-31
HU0000362D0 (en) 2000-04-28
ES2240005T3 (es) 2005-10-16
AU759179B2 (en) 2003-04-10
JP4659942B2 (ja) 2011-03-30
JP2011092190A (ja) 2011-05-12
KR100583259B1 (ko) 2006-05-25
MXPA00001001A (es) 2002-03-08
HUP0000362A2 (hu) 2000-11-28

Similar Documents

Publication Publication Date Title
HU0000362D0 (en) Novel antigenic class of avian reoviruses
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
DE69940264D1 (de) Krebsantigene, basierend auf dem tumorunterdrückenden genprodukt wt1
FR2763244B1 (fr) Composition vaccinale multivalente a porteur mixte
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
BR0012243A (pt) Triflúor butenos nematocidas
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
CY1106467T1 (el) Ελεγχομενη συνθεση ζιπρασιδονης
CY1106103T1 (el) Μεθοδος διαχωρισμου παραλλαγων ροταϊου και ζωντανο εξασθενημενο εμβολιο ροταϊου
AU7814498A (en) Multivalent (in ovo) avian vaccine
UA84284C2 (ru) Способы лечения, профилактики и диагностики инфекции helicobacter cerdo
DK1112747T3 (da) Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller
DK1147212T3 (da) T-hjælpecelle-epitoper
DK0838222T3 (da) Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV)
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
DK1442114T3 (da) Bakterie, der forårsager fjerkræsygdom og en vaccine afledt deraf
SG147465A1 (en) Vaccine
PE20010291A1 (es) Procedimiento para preparar un derivado de 10,11-metanodibenzosuberano
NZ510130A (en) Chicken anaemia viruses of low pathogenicity
RU98108898A (ru) Штамм "внивип-деп" для получения вакцины против реовирусного теносиновита кур
DK200000242U3 (da) Fodringsanlæg, især til fjerkræ, såsom kyllinger
DK1176193T3 (da) Hæmmere af virusinfektion, som angriber den n-terminale region af integrase
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner
ITSV20010001U4 (it) Vedi invenzione n. 16 del 1998
IT1314233B1 (it) Vaccino per hiv.